Untech


Untech is a drug development company dedicated to treating chronic wounds. They have developed a groundbreaking gel that addresses the three key stages of drug development: biotechnology, pre-clinical studies, and clinical studies. Their mission is to help the 120 million people worldwide suffering from chronic wounds by providing an effective healing solution. The team is composed of scientists and entrepreneurs with extensive experience in biotechnology and pharmaceutical industries, working to improve patient outcomes and bring definitive solutions to chronic health problems.

Industries

biotechnology
health-care
medical
pharmaceutical

Nr. of Employees

small (1-50)

Untech

Lewes, Delaware, United States, North America


Products

Topical therapeutic gel for chronic wounds

A topical gel formulation combining molecules and enzymes, designed to disrupt biofilm, exert antimicrobial effects, provide local anesthesia and promote biological processes associated with wound healing.


Services

Preclinical in vivo testing

Design and execution of animal studies to evaluate safety and efficacy of topical wound therapies prior to human trials.

Exploratory clinical study conduct

Execution of early-stage clinical studies to assess safety and therapeutic effectivity in patients with chronic wounds.

Expertise Areas

  • Chronic wound therapeutics
  • Topical formulation development
  • Antimicrobial and anti-biofilm therapeutics
  • Preclinical in vivo studies (wound models)
  • Show More (4)

Key Technologies

  • Topical hydrogel formulations
  • Biofilm-disruption methods
  • Antimicrobial susceptibility and biofilm assays
  • Matrix metalloproteinase (MMP) modulation
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.